Never miss the latest ESG news, interviews & insights. Subscribe for our weekly newsletter!

CreditAccess Partners With Apollo To Offer Cancer Screening & Primary Health Care Services in TN’s Cuddalore District

csr

Cuddalore, Oct 28, 2024: CreditAccess India Foundation, the CSR wing of microfinance institution CA Grameen, has signed a Memorandum of Understanding (MoU) with Apollo Telemedicine Networking Foundation (ATNF), a nonprofit organisation of the Apollo Hospitals group, to offer cancer screenings and primary health care services in Cuddalore district of Tamil Nadu.

The collaboration effective from August 2024 to March 2025 aims to screen over 11,000 beneficiaries across villages in the district. The services will include screenings of oral, breast, cervical, lung, oesophageal cancers. Additionally, primary healthcare consultations will be provided both on-site by an Apollo doctor and through teleconsultations with expert physicians from the Apollo Hospitals network. These essential screenings aim to ensure early detection of potential health issues, promoting proactive healthcare management and fostering a healthier community. 

Expressing his views, Ganesh Narayanan, Chief Executive Officer, CA Grameen, & Director, CAIF, said, "This partnership with Apollo Telemedicine Networking Foundation reaffirms our commitment to improving healthcare facilities in the underserved communities. By facilitating critical cancer screenings and offering primary health services to the people of Cuddalore, we aim to encourage early detection and support better health outcomes. This initiative not only addresses urgent healthcare needs but also lays the groundwork for long-term well-being and a healthier future for the community.”

Vikram Thaploo, Chief Executive Officer, Apollo Telemedicine Networking Foundation, said, "As we inaugurate this pivotal cancer screening program in Cuddalore in partnership with Credit Access India Foundation, we reaffirm our commitment to advancing public health. This program, which utilizes cutting-edge smart devices to screen for five types of cancers—including those particularly affecting women—marks a significant milestone in our efforts to enhance early detection and preventive care. By focusing on both technological innovation and the specific needs of women, we are not only addressing critical health concerns but also driving meaningful change in the lives of those we serve."

Subscribe to our Weekly Newsletter